| Lastest Insider Transactions Of Mineralys Therapeutics, Inc. ( MLYS ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-08-12 | Option Exercise | 11,365 | 0.84 | 9,565 | 2024-08-13 16:20:30 |
| MLYS | Mineralys Therapeutics, Inc. | Slingsby Brian Taylor | Directior 10% Owner | 2024-07-24 | Sell | 550,000 | 13.05 | 7,177,500 | 2024-07-26 21:45:51 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-07-16 | Sell | 525 | 15.00 | 7,876 | 2024-07-18 18:34:08 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-07-16 | Option Exercise | 525 | 1.08 | 567 | 2024-07-18 18:34:08 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-07-11 | Option Exercise | 11,366 | 0.84 | 9,566 | 2024-07-12 16:39:06 |
| MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO and Secretary | 2024-07-11 | Sell | 10,757 | 13.14 | 141,394 | 2024-07-12 16:37:59 |
| MLYS | Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer | 2024-07-11 | Sell | 15,746 | 13.34 | 210,075 | 2024-07-12 16:36:46 |
| MLYS | Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer | 2024-06-17 | Sell | 49,313 | 12.01 | 592,022 | 2024-06-20 17:44:01 |
| MLYS | Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer | 2024-06-12 | Sell | 72,797 | 12.70 | 924,203 | 2024-06-14 18:15:49 |
| MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO and Secretary | 2024-06-11 | Sell | 96,815 | 12.94 | 1,252,718 | 2024-06-13 17:33:32 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-06-11 | Option Exercise | 11,366 | 0.84 | 9,566 | 2024-06-13 17:32:09 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-05-13 | Option Exercise | 11,366 | 0.84 | 9,566 | 2024-05-15 16:43:17 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-05-09 | Sell | 100 | 15.00 | 1,500 | 2024-05-10 16:17:37 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-05-09 | Option Exercise | 100 | 1.08 | 108 | 2024-05-10 16:17:37 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-04-11 | Option Exercise | 11,366 | 0.84 | 9,566 | 2024-04-15 16:24:49 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-03-11 | Option Exercise | 11,365 | 0.84 | 9,565 | 2024-03-13 17:35:35 |
| MLYS | Mineralys Therapeutics, Inc. | Samsara BioCapital GP, LLC | 10% Owner | 2024-02-12 | Buy | 555,555 | 13.50 | 7,499,993 | 2024-02-14 21:06:11 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-02-12 | Option Exercise | 11,366 | 0.84 | 9,566 | 2024-02-13 16:08:54 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2024-01-11 | Option Exercise | 11,365 | 0.84 | 9,565 | 2024-01-12 16:01:35 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2023-12-11 | Option Exercise | 5,018 | 0.54 | 2,710 | 2023-12-12 17:08:45 |
| MLYS | Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer | 2023-11-22 | Buy | 4,250 | 5.97 | 25,356 | 2023-11-27 16:01:13 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2023-11-13 | Option Exercise | 5,017 | 0.54 | 2,709 | 2023-11-14 18:18:43 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2023-11-03 | Option Exercise | 10,034 | 0.54 | 5,418 | 2023-11-07 17:15:39 |
| MLYS | Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer | 2023-09-06 | Buy | 2,250 | 12.08 | 27,180 | 2023-09-08 08:49:26 |
| MLYS | Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer | 2023-08-17 | Buy | 2,250 | 12.10 | 27,225 | 2023-08-21 16:03:20 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2023-08-10 | Sell | 231,716 | 12.92 | 2,994,401 | 2023-08-11 19:11:30 |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | 2023-08-10 | Option Exercise | 231,716 | 0.72 | 166,265 | 2023-08-11 19:11:30 |
| MLYS | Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer | 2023-08-11 | Buy | 2,000 | 12.89 | 25,780 | 2023-08-11 19:11:15 |
| MLYS | Mineralys Therapeutics, Inc. | HBM Healthcare Investments (Cayman) Ltd. | 10% Owner | 2023-02-14 | Buy | 312,500 | 16.00 | 5,000,000 | 2023-02-16 21:00:28 |
| MLYS | Mineralys Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Directior | 2023-02-14 | Buy | 1,250,000 | 16.00 | 20,000,000 | 2023-02-16 17:04:34 |
| MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO, Chief Bus. Off. and Secy. | 2023-02-14 | Buy | 6,250 | 16.00 | 100,000 | 2023-02-16 16:54:40 |
| MLYS | Mineralys Therapeutics, Inc. | AKKARAJU SRINIVAS | Directior 10% Owner | 2023-02-14 | Buy | 937,500 | 16.00 | 15,000,000 | 2023-02-16 16:54:22 |
| MLYS | Mineralys Therapeutics, Inc. | Slingsby Brian Taylor | Directior 10% Owner | 2023-02-14 | Buy | 250,000 | 16.00 | 4,000,000 | 2023-02-16 16:54:03 |
